Member Info for joshing_man

Thanks Laura. I will check out the IMC videos today.

I bought in a few weeks ago and mostly seen the SP drop. Not a big amount and not a big deal. However, PYC is different to other 'biotech' or 'pharma' stock I hold/have held. and I need to get my head around it better. Happy to be pointed in the right direction with some links.

I'm waiting to add some more having read recent RNS's, read the BB comments especially by what appear to be knowledgeable posters. So, please forgive the naive questions but:

a) what are the main 'products' and offerings of PYC?

b) how do they make money - one-offs, recurring revenue, long term contracts?

c) what realistically are the prospects for PYC profits and more importantly for us as PI's the SP over the next 6,12 and 24 months?

d) linked to the above, what would be the catalyst(s) to PYC taking off?

Again, apologies if you think I'm being dumb or lazy but I am intrigued and suffering from a lack of time at the moment. Any help would be appreciated.

I think other health jurisdictions may well be more profitable too.

However, I have e-mailed Walbrook to ask for an interview/presentation from Dr Miele with regards to progress, timescales, numbers, limitations imposed by the preference for lab testing etc. Of course they are not going to be able to give privileged information but the issue of lab testing and the lack of news on sales is an issue and can be addressed/allayed with some guidance as to prospects - ditto AIHL. The lack of penetration must be a concern to them.

She does play both sides depending whether in or out!

EC's ramping is pretty amusing but Popeye's deramping is just as annoying.

GDR needs to get its act together and prove itself. It does have 2 great machines and tests BUT getting them used isn't a quick and easy win and no-one should think it is. GDR has a future BUT it needs to sort cash burn and the best way to do that is get the sales going. They've started but it is small. Now we need to see this grow and do so quickly.

The new CEO needs to up the PR game and find a way to stop the cash outflows being so high. Getting rid of Cheek is a step in the right direction.

He doesn't irritate me. Posters who only post about Skelly do.

October we get to know the timeline for the DFS but realistically it will be end H1 or into H2 2025 before DFS completed. Reading the RNS I got the feeling that KC is only the mouthpiece for EMH shareholders. He no longer appears to have any clout or say in what happens and when. Whether that is good or bad is debateable but hopefully CEZ will deliver. Holding in hope that we will see a reward for our patience.

Whoops! D'oh. Point remains valid sadly although maybe a tad premature. Nice one Skelly!

So a new 'deadline' of 31st October it is - not a great surprise to most of us I suggest. Let's hope it is a Treat and not a Trick! Don't want to see any ghosts of failures past or a zombie share!

Yes, that's the one. Sounds positive but .......

Let's hope so but having trawled a long way back the link I found simply states 'expected publication date'. That should be good enough but having been bitten on many shares by reality not meeting expectations (timeline wise) I will not count the chickens (or the profits) just yet.

So one week to go ..... or is it?

I do not think it will be earlier as that just doesn't seem to be the norm. I do think it could be later as Lionel 1 reports that NICE have stated this is 'the earliest' the announcement will be made.

I do not agree with the serious negativity of Stocksaint and Systemzero but I am ready for some volatility if the expected outcome doesn't happen on 31st July but at a later date. Either way I'm in profit now and expect to be in much bigger profit by the end of the year.

I too think it is a given. Not so certain that 31st July is but hope so.

Never received a reply to any e-mails to Keith

The incessant ramping from a newbie doesn't help either!

Agree Lukas, however the deafening silence from Keith is why so many of us are fed up. He should step up to the plate and explain/confirm the delay in DFS and the likely timescale for a new one. Thankfully, numpties such as Wise (in his multiple disguises) has stopped saying it was imminent. What we do want though is an honest assessment and some humility from Keith. Perhaps those who have an inside track can ask him nicely to put out an official RNS confirming or denying the latest reports. The project is good but the management of the project has been abject. That could be down to EU incompetence, Czech government interference or CEZ looking to lever EMH out of the picture. I have no doubt Keith will be fine, I'm no longer so sure about my investment.

Why? Skelly is asking sensible questions but getting dogs abuse from holders who don't appear to care that KC has made a pigs ear of this asset. Holders or not the view is valid.

I emailed KC yesterday asking very similar questions. Thus 6 months on from the previous unanswered email.

Skelly is asking questions genuine holders (such as me) would like answers to Colin. Why shoot the messenger? We have been misled by KC and Cez and the SP is in the doldrums. My view is that it is still a good time to buy (assuming we believe this will come to fruition in a reasonable timeframe and with EMH still involved).

Espen is new so is assuming all uphill from now. The rest are more wary but we do have the opportunity to buy at historically low price. Some believe it may go lower first.

The PR and communications are dreadful. This has left a very sour taste even for those of us with low averages.

I too am new to the share. The issue appears to be fulfilling the orders due to incompetence and/or poor processes leading to very high scrappage rate.

Would like to hear this is being addresses.

Mine too on AJ Bell. 3.3p average in SIPP and 2.3p in GIA or thereabouts